These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32748745)

  • 1. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
    Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
    Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
    Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
    Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer.
    Youngren-Ortiz SR; Chougule MB
    Hawaii J Med Public Health; 2017 Nov; 76(11):318-325. PubMed ID: 29164017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.
    Korucu Aktas P; Baysal I; Yabanoglu-Ciftci S; Lamprecht A; Arica B
    Int J Pharm; 2024 Jan; 650():123703. PubMed ID: 38092263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
    Babu A; Munshi A; Ramesh R
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
    Subhan MA; Torchilin VP
    Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.
    Amreddy N; Ahmed RA; Munshi A; Ramesh R
    Methods Mol Biol; 2020; 2059():167-189. PubMed ID: 31435921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.
    Kim YD; Park TE; Singh B; Maharjan S; Choi YJ; Choung PH; Arote RB; Cho CS
    Nanomedicine (Lond); 2015; 10(7):1165-88. PubMed ID: 25929572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-component bioresponsive nanoparticles for synchronous delivery of docetaxel and TUBB3 siRNA to lung cancer cells.
    Conte C; Monteiro PF; Gurnani P; Stolnik S; Ungaro F; Quaglia F; Clarke P; Grabowska A; Kavallaris M; Alexander C
    Nanoscale; 2021 Jul; 13(26):11414-11426. PubMed ID: 34160534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.
    Zhang C; Zhao Y; Zhang E; Jiang M; Zhi D; Chen H; Cui S; Zhen Y; Cui J; Zhang S
    Drug Deliv; 2020 Dec; 27(1):1397-1411. PubMed ID: 33096948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
    Amreddy N; Babu A; Panneerselvam J; Srivastava A; Muralidharan R; Chen A; Zhao YD; Munshi A; Ramesh R
    Nanomedicine; 2018 Feb; 14(2):373-384. PubMed ID: 29155362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
    Ezhilarasan D; Lakshmi T; Mallineni SK
    Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles containing insoluble drug for cancer therapy.
    Guo S; Huang L
    Biotechnol Adv; 2014; 32(4):778-88. PubMed ID: 24113214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers.
    Yaghmur A; Østergaard J; Mu H
    Adv Drug Deliv Rev; 2023 Dec; 203():115136. PubMed ID: 37944644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.
    Beyaz H; Uludag H; Kavaz D; Rizaner N
    Adv Exp Med Biol; 2021; 1347():163-181. PubMed ID: 34287795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.